Calithera Biosciences Inc (NASDAQ:CALA) shares are trading higher by $1.45 (10 percent) at $16.85 in Wednesday's session.
Before the open, the company reported it received FDA Fast Track Designation for CB-839 for the treatment of patients with Renal Cell Carcinoma.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
After a higher open, Calithera had a brief retreat but found support above Tuesday's close ($15.40) at $15.65 and continued its move higher. It took the stock to $17.25, but has fallen back to the $17.00 area.
That high comes in just above its May 24 high ($17.20), but is shy of its May 23 high ($17.40).